Methionine aminopeptidase (type 2) is the common target for angiogenesis inhibitors AGM-1470 and ovalicin

Chemistry and Biology

Volumn 4, Issue 6, 1997, Pages 461-471

  Griffith, Eric C ^a   Su, Zhuang ^a   Turk, Benjamin E ^a   Chen, Shaoping ^b   Chang, Yie Hwa ^b   Wu, Zhuchun ^a   Biemann, Klaus ^a   Liu, Jun O ^a  

^a MASSACHUSETTS INSTITUTE OF TECHNOLOGY   (United States)

^b SAINT LOUIS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

AGM 1470; Angiogenesis; Methionine aminopeptidase; Ovalicin

Indexed keywords

AERIES; ANIMALIA; BOS TAURUS; EUKARYOTA;

EID: 0031171961     PISSN: 10745521     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1074-5521(97)90198-8     Document Type: Article

References (53)

1. Folkman, J. (1985). Tumor angiogenesis. Adv. Cancer Res. 43, 175-203.
2. Folkman, J. (1990). What is the evidence that tumors are angiogenesis dependent? J. Natl Cancer Inst. 82, 4-6.
3. Risau, W. (1997). Mechanisms of angiogenesis. Nature 386, 671-674.
4. Gimbrone, M.A.J., Leapman, S.B., Cotran, R.S. & Folkman, J. (1972). Tumor dormancy in vivo by prevention of neovascularization. J. Exp. Med. 136, 261-276.
5. Hanahan, D. & Folkman, J. (1996). Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis. Cell 86, 353-364.
6. Brem, S., Brem, H., Folkman, J., Finkelstein, D. & Patz, A. (1976). Prolonged tumor dormancy by prevention of neovascularization in the vitreous. Cancer Res. 36, 2807-2812.
7. Holmgren, L., O'Reilly, M.S. & Folkman, J. (1995). Dormancy of micrometastases: balanced proliferation and apoptosis in the presence of angiogenesis suppression. Nat. Med. 1, 149-153.
8. Parangi, S., et al., & Hanahan, D. (1996). Antiangiogenic therapy of transgenic mice impairs de novo tumor growth. Proc. Natl Acad. Sci. USA 93, 2002-2007.
9. Hanson, F.R. & Eble, T.E. (1949). An antiphage agent isolated from Aspergillus sp. J. Bacteriol. 58, 527-529.
10. McCowen, M., Callender, M. & Lawlis, J. (1951). Fumagillin (H-3), a new antibiotic with amebicidal properties. Science 113, 202-203.
11. Ingber, D., et al., & Folkman, J. (1990). Synthetic analogues of fumagillin that inhibit angiogenesis and suppress tumor growth. Nature 348, 555-557.
12. Toi, M., Takayanagi, T., Souma, R. & Tominaga, T. (1994). Inhibition of vascular endothelial growth factor induced cell growth by an angiogenesis inhibitor AGM-1470 in capillary endothelial cells. Oncology Reports 1, 423-426.
13. Yamamoto, T., Sudo, K. & Fujita, T. (1994). Significant inhibition of endothelial cell growth in tumor vasculature by an angiogenesis inhibitor, TNP-470 (AGM-1470). Anticancer Res. 14, 1-4.
14. Sigg, H.P. & Weber, H.P. (1968). Isolation and structure elucidation of ovalicin. Helv. Chim. Acta 51, 1395-1408.
15. Bollinger, P., Sigg, H.P. & Weber, H.P. (1973). Structure of ovalicin. Helv. Chim. Acta 56, 819-830.
16. Zimmerman, W.A. & Hartmann, G.R. (1981). On the mode of action of the immunosuppressive sesquiterpene ovalicin. Eur. J. Biochem. 118, 143-150.
17. Borel, J.F., Lazary, S. & Staehelin, H. (1974). Immunosuppressive effects of ovalicin-semicarbazone. Agents Actions 4, 357-363.
18. Corey, E.J., Guzman-Perez, A. & Noe, M.C. (1994). Enantioselective synthesis of (-)-ovalicin, a potent inhibitor of angiogenesis, using substrate-enhanced catalytic asymmetric hydroxylation. J. Am. Chem. Soc. 116, 12109-12110.
19. Marui, S., Itoh, F., Kozai, Y., Sudo, K. & Kishimoto, S. (1992). Chemical modification of fumagillin. I. 6-O-Acyl, 6-O-sulfonyl, 6-O-alkyl and 6-O-(N-substituted carbamoyl)fumagillols. Chem. Pharm. Bull. 40, 96-101.
20. 1 phase of the cell cycle. Cancer Res. 54, 2073-2076.
21. Breier, G., Albrecht, U., Sterrer, S. & Risau, W. (1992). Expression of vascular endothelial growth factor during embryonic angiogenesis and endothelial cell differentiation. Development 114, 521-532.
22. Shevchenko, A., et al., & Mann, M. (1996). Link genome and proteome by mass spectrometry: large-scale identification of yeast proteins from two dimensional gels. Proc. Natl Acad. Sci. USA 93, 14440-14445.
23. Wu, S., et al., & Gupta, N.K. (1993). Cloning and characterization of complementary DNA encoding the eukaryotic initiation factor-2 associated 67-kDa protein (p67). J. Biol. Chem. 268, 10796-10801.
24. Li, X. & Chang, Y.-H. (1995). Molecular cloning of a human complementary DNA encoding an initiation factor 2-associated protein (p67). Biochim. Biophys. Acta 1260, 333-336.
25. Arfin, S.M., et al., & Bradshaw, R.A. (1995). Eukaryotic methionyl aminopeptidases: two classes of cobalt-dependent enzymes. Proc. Natl Acad. Sci. USA 92, 7714-7718.
26. Li, X. & Chang, Y.-H. (1996). Evidence that the human homologue of a rat initiation factor-2 associated protein (p67) is a methionine aminopeptidase. Biochem. Biophys. Res. Commun. 227, 152-159.
27. Datta, B., Chakrabarti, D., Roy, A.L. & Gupta, N.K. (1988). Roles of a 67-kDa polypeptide in reversal of protein synthesis inhibition in heme-deficient reticulocyte lysate. Proc. Natl Acad. Sci. USA 85, 3324-3328.
28. Ray, M.K., Datta, B., Chakraborly, A., Chattopadhyay, A., Meza-Keuthen, S. & Gupta, N.K. (1992). The eukaryotic initiation factor 2-associated 67-kDa polypeptide (p67) plays a critical role in regulation of protein synthesis initiation in animal cells. Proc. Natl Acad. Sci. USA 89, 539-543.
29. Gross, M. & Rabinovitz, M. (1972). Control of globin synthesis by hemin: factors influencing formation of an inhibitor of globin chain initiation in reticulocyte lysates. Biochim. Biophys. Acta 287, 340-352.
30. Chang, Y-H., Teichert, U. & Smith, J.A. (1990). Purification and characterization of a methionine aminopeptidase from Saccharomyces cerevisiae. J. Biol. Chem. 265, 19892-19897.
31. Chang, Y-H., Teichert, U. & Smith, J.A. (1992). Molecular cloning, sequencing, deletion, and overexpression of a methionine aminopeptidase gene from Saccharomyces cerevisiae. J. Biol. Chem. 267, 8007-8011.
32. Li, X. & Chang, Y.-H. (1995). Amino-terminal protein processing in Saccharomyces cerevisiae is an essential function that requires two distinct methionine aminopeptidases. Proc. Natl Acad. Sci. USA 92, 12357-12361.
33. Kusaka, M., et al., & Folkman, J. (1994). Cytostatic inhibition of endothelial cell growth by the angiogenesis inhibitor TNP-470 (AGM-1470). Br. J. Cancer 69, 212-216.
34. Abe, J., et al., & Takuwa, Y. (1994). A fumagillin derivative angiogenesis inhibitor, AGM-1470, inhibits activation of cyclin-dependent kinases and phosphorylation of retinoblastoma gene product but not protein tyrosyl phosphorylation or protooncogene expression in vascular endothelial cells. Cancer Res. 54, 3407-3412.
35. Chang, S.Y., McGary, E.C. & Chang, S. (1989). Methionine aminopeptidase gene of Escherichia coli is essential for cell growth. J. Bacteriol. 171, 4071-4072.
36. src prevents both myristoylation and morphological transformation. Proc. Natl Acad. Sci. USA 82, 4625-4628.
37. Aitken, M., Klee, C.B. & Cohen, P. (1984). The structure of the B subunit of calcineurin. Eur. J. Biochem. 139, 663-671.
38. Sewell, J.L. & Kahn, R.A. (1988). Sequences of the bovine and yeast ADP-ribosylation factor and comparison to other GTP-binding proteins. J. Biol. Chem. 85, 4620-4624.
39. Varshavsky, A. (1997). The N-end rule pathway of protein degradation. Genes Cells 2, 13-28.
40. Zuo, S., Guo, Q., Ling, C., Chang, Y-.H. (1995). Evidence that two zinc fingers in the methionine aminopeptidase from Saccharomyces cerevisiae are important for normal growth. Mol. Gen. Genet 246, 247-253.
41. Beetham, J.K., et al., & Hammock, B. D. (1995). Gene evolution of epoxide hydrolases and recommended nomenclature. DNA Cell Biol. 14, 61-71.
42. Lazary, S. & Stahelin, H. (1968). Immunosuppressive and specific antimitotic effects of ovalicin. Experientia 24, 1171-1173.
43. Lazary, S. & Stahelin, H. (1969). Immunosuppressive effect of a new antibiotic: ovalicin. Antibiot. Chemother. 15, 177-181.
44. Lazary, S. & Stahelin, H. (1970). Ovalicin and other drugs in experimental allergic encephalomyelitis. Experientia 26, 691.
45. Hartmann, G.R., Richter, H., Weiner, E.M. & Zimmermann, W. (1978). On the mechanism of action of the cytostatic drug anguidine and of the immunosuppressive agent ovalicin, two sesquiterpenes from fungi. Planta medica 34, 231-252.
46. Hatanaka, H., et al., & Okuhara, M. (1988). FR65814, a novel immunosuppressant isolated from a Penicillium strain: taxonomy, fermentation, isolation, physico-chemical and biological characteristics and structure assignment. J. Antibiot. 8, 999-1008.
47. Antoine, N., Bours, V., Heinen, E., Simar, L.J. & Castronovo, V. (1995). Stimulation of human B-lymphocyte proliferation by AGM-1470, a potent inhibitor of angiogenesis. J. Natl Cancer Inst. 87, 136-139.
48. Antoine, N., Daukandt, M., Heinen, E., Simar, L.J. & Castronovo, V. (1996). In vitro and in vivo stimulation of the murine immune system by AGM-1470, a potent angiogenesis inhibitor. Am. J. Pathol. 148, 393-398.
49. Tarbell, D.S., et al., & West, R.L. (1961). The chemistry of fumagillin. J. Am. Chem. Soc. 83, 3096-3113.
50. Radomski, N. & Jost, E. (1995). Molecular cloning of a murine cDNA encoding a novel protein, p38-2G4, which varies with the cell cycle. Exp. Cell Res 220, 434-445.
51. Turk, B.E., Jiang, H. & Liu, J.O. (1996). Binding of thalidomide to α1-acid glycoprotein may be involved in its inhibition of tumor necrosis factor α production. Proc. Natl Acad. Sci. USA 93, 7552-7556.
52. Shevchenko, A., Wilm, M., Vorm, O. & Mann, M. (1996). Mass spectrometric sequencing of proteins from silver-stained polyacrylamide. Anal. Chem. 68, 850-858.
53. Vestal, M.L., Juhase, P. & Martin, S.A. (1995). Delayed extraction matrix-assisted laser desorption time-of-flight mass spectrometry. Rapid Commun. Mass Spectrom. 9, 1044-1050.